Thyroid dysfunction and survival in cancer patients treated with immune checkpoint inhibitors: analyses from a large single tertiary cancer center database-Reference-Cited by-同舟云学术

Thyroid dysfunction and survival in cancer patients treated with immune checkpoint inhibitors: analyses from a large single tertiary cancer center database

Published:2021-08-11 Issue:11 Volume:60 Page:1466-1471
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Percik Ruth¹²³^ORCID,Liel Yair⁴^ORCID,Urban Damien³⁵,Bar Jair³⁵,Ben-Ami Eytan³⁵,Abu Tailakh Muhammad⁶⁷^ORCID

Affiliation:

1. Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Tel Hashomer, Israel

2. Institute of Oncology, Endo-Oncology Clinic, Tel Hashomer, Israel

3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

4. Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

5. Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel

6. Department of Nursing, Recanati School for Community Health Professions, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

7. Soroka University Medical Center, Beer-Sheva, Israel

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1958006

Reference35 articles.

1. Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy

3. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints

4. Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab

5. Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer;Heliyon;2024-03

2. Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression during neoadjuvant therapy of non‑small cell lung cancer: A case report and literature review;Oncology Letters;2023-09-29

3. Immune checkpoint inhibitor–related adverse events: Real-world experience from a single veterans’ affairs medical center;Journal of Oncology Pharmacy Practice;2023-06-23

4. Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report;Cureus;2023-05-24

5. Immune checkpoint inhibitor-related thyroid dysfunction;Annales d'Endocrinologie;2023-05